BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy14722
(87 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 45 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 98
Score = 63.2 bits (152), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 60 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 101
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 42 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Score = 63.2 bits (152), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 57 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 98
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin
A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin
A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex
With A Peptide Containing Both The Substrate And
Recruitment Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex
With A Peptide Containing Both The Substrate And
Recruitment Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 38 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 91
Score = 63.2 bits (152), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 53 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 94
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A
Complexed With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A
Complexed With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
F82h-L83v- H84d Mutant With An
O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
F82h-L83v- H84d Mutant With An
O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 40 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 93
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 55 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 96
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN
OXINDOLE Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN
OXINDOLE Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-
Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-
Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
Length = 260
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 40 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 93
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 55 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 96
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 38 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 91
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 53 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 94
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 39 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 92
Score = 63.2 bits (152), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 54 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 95
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
Length = 261
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 41 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 94
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 56 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 97
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 36 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 89
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 51 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 92
>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 261
Score = 79.0 bits (193), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 41 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 94
Score = 63.2 bits (152), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 56 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 97
>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 257
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 38 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 91
Score = 63.2 bits (152), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 53 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 94
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 42 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 57 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 98
>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 258
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 38 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 91
Score = 63.2 bits (152), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 53 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 94
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Roscovitine
Length = 269
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 42 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 57 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 98
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Cr8
Length = 268
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 42 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 57 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 98
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 42 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 57 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 98
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 42 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 57 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 98
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 42 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 57 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 98
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 42 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 57 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 98
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 79.0 bits (193), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 35/54 (64%), Positives = 45/54 (83%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
A+ V ++EV EEYK+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS
Sbjct: 42 AILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Score = 63.2 bits (152), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 28/42 (66%), Positives = 35/42 (83%)
Query: 1 MHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
+ NETLHLA+NY+DRFLS MSV+R KLQL+GT A+ +AS E
Sbjct: 57 LQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLASKFE 98
>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type
Cyclin
Length = 257
Score = 62.8 bits (151), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 28/48 (58%), Positives = 35/48 (72%)
Query: 40 IIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
++EV EE K E LA+NY+DRFLSL V +S+LQLLG T +FVAS
Sbjct: 50 MLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVAS 97
Score = 52.0 bits (123), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 23/38 (60%), Positives = 28/38 (73%)
Query: 2 HNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 39
E LA+NY+DRFLSL V +S+LQLLG T +FVAS
Sbjct: 60 EEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVAS 97
>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 271
Score = 57.8 bits (138), Expect = 2e-09, Method: Composition-based stats.
Identities = 28/48 (58%), Positives = 35/48 (72%)
Query: 40 IIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
++EV EE K E LA+NY+DRFLSL V +S+LQLLG T +FVAS
Sbjct: 64 MLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVAS 111
Score = 48.5 bits (114), Expect = 9e-07, Method: Composition-based stats.
Identities = 23/36 (63%), Positives = 28/36 (77%)
Query: 4 ETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 39
E LA+NY+DRFLSL V +S+LQLLG T +FVAS
Sbjct: 76 EVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVAS 111
>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
Length = 283
Score = 47.8 bits (112), Expect = 2e-06, Method: Composition-based stats.
Identities = 22/55 (40%), Positives = 41/55 (74%), Gaps = 1/55 (1%)
Query: 34 ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLM-SVVRSKLQLLGTTALFVAS 87
A+ + ++EV E YK+H ET +LA ++ DR+++ +VV++ LQL+G ++LF+A+
Sbjct: 51 AILLDWLMEVCEVYKLHRETFYLAQDFFDRYMATQENVVKTLLQLIGISSLFIAA 105
Score = 40.0 bits (92), Expect = 3e-04, Method: Composition-based stats.
Identities = 19/51 (37%), Positives = 36/51 (70%), Gaps = 1/51 (1%)
Query: 1 MHNETLHLAINYVDRFLSLM-SVVRSKLQLLGTTALFVASIIEVAEEYKMH 50
+H ET +LA ++ DR+++ +VV++ LQL+G ++LF+A+ +E K+H
Sbjct: 66 LHRETFYLAQDFFDRYMATQENVVKTLLQLIGISSLFIAAKLEEIYPPKLH 116
>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
Length = 306
Score = 46.6 bits (109), Expect = 3e-06, Method: Composition-based stats.
Identities = 20/48 (41%), Positives = 32/48 (66%)
Query: 40 IIEVAEEYKMHNETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 87
++EV EE + E LA+NY+DR+LS + +++LQLLG + +AS
Sbjct: 78 MLEVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQLQLLGAVCMLLAS 125
Score = 38.5 bits (88), Expect = 0.001, Method: Composition-based stats.
Identities = 16/36 (44%), Positives = 25/36 (69%)
Query: 4 ETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVAS 39
E LA+NY+DR+LS + +++LQLLG + +AS
Sbjct: 90 EVFPLAMNYLDRYLSCVPTRKAQLQLLGAVCMLLAS 125
>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
Length = 269
Score = 46.2 bits (108), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 26/79 (32%), Positives = 46/79 (58%), Gaps = 7/79 (8%)
Query: 15 RFLSLMSVVRSKLQLLGTT------ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLM 68
R L VR K LLG A+ + +++V ++++ ET+++ ++ +DRF+
Sbjct: 15 RQLEAAQAVRPKY-LLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNN 73
Query: 69 SVVRSKLQLLGTTALFVAS 87
SV + LQL+G TA+F+AS
Sbjct: 74 SVPKKMLQLVGVTAMFIAS 92
Score = 40.4 bits (93), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 3 NETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
ET+++ ++ +DRF+ SV + LQL+G TA+F+AS E
Sbjct: 56 QETMYMTVSIIDRFMQNNSVPKKMLQLVGVTAMFIASKYE 95
>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin
B
Length = 260
Score = 44.3 bits (103), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 45/79 (56%), Gaps = 7/79 (8%)
Query: 15 RFLSLMSVVRSKLQLLGTT------ALFVASIIEVAEEYKMHNETLHLAINYVDRFLSLM 68
R L VR K LLG A+ + +++V ++++ ET+++ ++ +DRF+
Sbjct: 13 RQLEEEQAVRPKY-LLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNN 71
Query: 69 SVVRSKLQLLGTTALFVAS 87
V + LQL+G TA+F+AS
Sbjct: 72 CVPKKMLQLVGVTAMFIAS 90
Score = 39.3 bits (90), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 16/40 (40%), Positives = 27/40 (67%)
Query: 3 NETLHLAINYVDRFLSLMSVVRSKLQLLGTTALFVASIIE 42
ET+++ ++ +DRF+ V + LQL+G TA+F+AS E
Sbjct: 54 QETMYMTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYE 93
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.326 0.135 0.358
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 1,768,800
Number of Sequences: 62578
Number of extensions: 47259
Number of successful extensions: 182
Number of sequences better than 100.0: 30
Number of HSP's better than 100.0 without gapping: 30
Number of HSP's successfully gapped in prelim test: 0
Number of HSP's that attempted gapping in prelim test: 122
Number of HSP's gapped (non-prelim): 58
length of query: 87
length of database: 14,973,337
effective HSP length: 55
effective length of query: 32
effective length of database: 11,531,547
effective search space: 369009504
effective search space used: 369009504
T: 11
A: 40
X1: 15 ( 7.0 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.7 bits)
S2: 45 (21.9 bits)